Ida B. Gottschalck

452 total citations
13 papers, 354 citations indexed

About

Ida B. Gottschalck is a scholar working on Nutrition and Dietetics, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ida B. Gottschalck has authored 13 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nutrition and Dietetics, 5 papers in Genetics and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ida B. Gottschalck's work include Clinical Nutrition and Gastroenterology (6 papers), Inflammatory Bowel Disease (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Ida B. Gottschalck is often cited by papers focused on Clinical Nutrition and Gastroenterology (6 papers), Inflammatory Bowel Disease (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Ida B. Gottschalck collaborates with scholars based in Denmark and Austria. Ida B. Gottschalck's co-authors include Palle Bekker Jeppesen, Jens J. Holst, Preben Bo Mortensen, Dennis B. Henriksen, Bolette Hartmann, Jann Mortensen, P. Lund, Bjørn Quistorff, Michael Staun and Steen Seier Poulsen and has published in prestigious journals such as Gastroenterology, Vaccine and Scandinavian Journal of Gastroenterology.

In The Last Decade

Ida B. Gottschalck

13 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ida B. Gottschalck Denmark 8 146 101 84 78 65 13 354
Lauren K. Schwartz United States 6 194 1.3× 91 0.9× 76 0.9× 20 0.3× 90 1.4× 11 311
Shannon Longshore United States 9 85 0.6× 77 0.8× 70 0.8× 11 0.1× 45 0.7× 26 289
Umar Amin Qureshi India 12 97 0.7× 54 0.5× 40 0.5× 55 0.7× 68 1.0× 22 365
Michael D. Levitt United States 11 52 0.4× 71 0.7× 119 1.4× 21 0.3× 57 0.9× 13 339
Raffael Ott Germany 12 27 0.2× 71 0.7× 122 1.5× 29 0.4× 82 1.3× 27 393
Lowry Sf United States 10 91 0.6× 82 0.8× 104 1.2× 22 0.3× 77 1.2× 18 384
D N L Ralphs United Kingdom 13 55 0.4× 89 0.9× 307 3.7× 114 1.5× 45 0.7× 28 575
I Loras-Duclaux France 11 182 1.2× 34 0.3× 140 1.7× 9 0.1× 36 0.6× 29 366
Babette S. Zemel United States 6 98 0.7× 55 0.5× 76 0.9× 14 0.2× 52 0.8× 6 340
Sivan Ben‐Avraham Israel 7 45 0.3× 99 1.0× 93 1.1× 50 0.6× 8 0.1× 14 368

Countries citing papers authored by Ida B. Gottschalck

Since Specialization
Citations

This map shows the geographic impact of Ida B. Gottschalck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ida B. Gottschalck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ida B. Gottschalck more than expected).

Fields of papers citing papers by Ida B. Gottschalck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ida B. Gottschalck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ida B. Gottschalck. The network helps show where Ida B. Gottschalck may publish in the future.

Co-authorship network of co-authors of Ida B. Gottschalck

This figure shows the co-authorship network connecting the top 25 collaborators of Ida B. Gottschalck. A scholar is included among the top collaborators of Ida B. Gottschalck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ida B. Gottschalck. Ida B. Gottschalck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Kiszka‐Kanowitz, Marianne, Klaus Theede, Jacob Tveiten Bjerrum, et al.. (2022). Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial. EClinicalMedicine. 45. 101332–101332. 17 indexed citations
2.
Kantsø, Bjørn, Sofie Ingdam Halkjær, Ole Østergaard Thomsen, et al.. (2019). Persistence of antibodies to pneumococcal conjugate vaccine compared to polysaccharide vaccine in patients with Crohn’s disease – one year follow up. Infectious Diseases. 51(9). 651–658. 6 indexed citations
3.
Kantsø, Bjørn, Sofie Ingdam Halkjær, Ole Østergaard Thomsen, et al.. (2015). Immunosuppressive drugs impairs antibody response of the polysaccharide and conjugated pneumococcal vaccines in patients with Crohn's disease. Vaccine. 33(41). 5464–5469. 36 indexed citations
4.
Kantsø, Bjørn, Sofie Ingdam Halkjær, Erika Bélard, et al.. (2015). 926 Specific Antibody Response to Two Pneumococcal Vaccines in Crohn's Disease Patients Treated With Immunosuppressive Drugs Alone or in Combination With Biological Therapy. Gastroenterology. 148(4). S–176. 1 indexed citations
5.
Jeppesen, Palle Bekker, P. Lund, Ida B. Gottschalck, et al.. (2009). Short Bowel Patients Treated for Two Years with Glucagon-Like Peptide 2 (GLP-2): Compliance, Safety, and Effects on Quality of Life. Gastroenterology Research and Practice. 2009. 1–9. 36 indexed citations
6.
Jeppesen, Palle Bekker, P. Lund, Ida B. Gottschalck, et al.. (2009). Short Bowel Patients Treated for Two Years with Glucagon-Like Peptide 2: Effects on Intestinal Morphology and Absorption, Renal Function, Bone and Body Composition, and Muscle Function. Gastroenterology Research and Practice. 2009. 1–12. 75 indexed citations
7.
Gottschalck, Ida B., Palle Bekker Jeppesen, Bolette Hartmann, Jens J. Holst, & Dennis B. Henriksen. (2008). Effects of treatment with glucagon-like peptide-2 on bone resorption in colectomized patients with distal ileostomy or jejunostomy and short-bowel syndrome. Scandinavian Journal of Gastroenterology. 43(11). 1304–1310. 37 indexed citations
8.
Gottschalck, Ida B., Palle Bekker Jeppesen, Jens J. Holst, & Dennis B. Henriksen. (2008). Reduction in bone resorption by exogenous glucagon-like peptide-2 administration requires an intact gastrointestinal tract. Scandinavian Journal of Gastroenterology. 43(8). 929–937. 35 indexed citations
9.
Jeppesen, Palle Bekker, Ida B. Gottschalck, Jens J. Holst, Preben Bo Mortensen, & Bolette Hartmann. (2008). 756 Two Dose-Equivalent, 21-Days, Subcutaneous (S.C.), Glucagon-Like Peptide 2 (GLP-2) Dosing Regimens, 1.0 Mg Continuously Versus 0.33 Mg Three Time Daily (tid), in the Treatment of Short Bowel Syndrome (SBS) Patients. Gastroenterology. 134(4). A–110. 1 indexed citations
10.
Jeppesen, Palle Bekker, Ida B. Gottschalck, Jens J. Holst, Barry J. Hartman, & Preben Bo Mortensen. (2008). P093 TWO DOSE-EQUIVALENT, 21-DAYS, SUBCUTANEOUS (S.C.), GLUCAGON-LIKE PEPTIDE 2 (GLP-2) DOSING REGIMENS, 1.0 MG CONTINUOUSLY VERSUS 0.33 MG THREE TIME DAILY (TID), IN THE TREATMENT OF SHORT BOWEL SYNDROME (SBS) PATIENTS. Clinical Nutrition Supplements. 3. 68–68. 1 indexed citations
11.
Jeppesen, Palle Bekker, Ida B. Gottschalck, Jens J. Holst, & Preben Bo Mortensen. (2008). M1824b Improvements in Renal Function in Short Bowel Syndrome (SBS) Patients Treated for Two Years with Subcutaneous Native Glucagon-Like Peptide 2 (GLP-2). Gastroenterology. 134(4). A–427. 1 indexed citations
12.
Holst, Jens J., Bolette Hartmann, Ida B. Gottschalck, et al.. (2007). Bone resorption is decreased postprandially by intestinal factors and glucagon-like peptide-2 is a possible candidate. Scandinavian Journal of Gastroenterology. 42(7). 814–820. 36 indexed citations
13.
Gottschalck, Ida B., et al.. (2005). Home parenteral nutrition in Denmark in the period from 1996 to 2001. Scandinavian Journal of Gastroenterology. 41(4). 401–407. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lauren K. Schwartz Breakdown of academic impact, for papers by Shannon Longshore Breakdown of academic impact, for papers by Umar Amin Qureshi Breakdown of academic impact, for papers by Michael D. Levitt Breakdown of academic impact, for papers by Raffael Ott Breakdown of academic impact, for papers by Lowry Sf Breakdown of academic impact, for papers by D N L Ralphs Breakdown of academic impact, for papers by I Loras-Duclaux Breakdown of academic impact, for papers by Babette S. Zemel Breakdown of academic impact, for papers by Sivan Ben‐Avraham
Rankless by CCL
2026